Table 2.
Adverse Event | Any Grade | Grade 3–4 |
---|---|---|
Upper resperatory infection | 11 (91.6%) | 0 |
Increased bowel movement frequency | 4 (33.3%) | 0 |
Blood on Urinalysis | 4 (33.3%) | |
Loose stools | 3 (25%) | 0 |
Mild acne | 3 (25%) | 0 |
Weight Gain | 2 (16.6%) | 0 |
Asymptomatic bacteriuria | 2 (16.6%) | |
Hypertensive Urgency | 1 (8.3%) | 1 (8.3%) |
Bloating | 1 (8.3%) | 0 |
Constipation | 1 (8.3%) | 0 |
Dizziness | 1 (8.3%) | 0 |
Headache | 1 (8.3%) | 0 |
Neuropathic pain | 1 (8.3%) | 0 |
Vaginal spotting (post menopause) | 1 (8.3%) | 0 |
Conjunctivitis | 1 (8.3%) | 0 |
Urinary Retention | 1 (8.3%) | 0 |
Transaminitis | 1 (8.3%) | 0 |